South Korea · Delayed Price · Currency is KRW Psomagen Statistics
Total Valuation
Psomagen has a market cap or net worth of KRW 70.02 billion. The enterprise value is 69.56 billion.
| Market Cap | 70.02B |
| Enterprise Value | 69.56B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Psomagen has 19.24 million shares outstanding. The number of shares has decreased by -2.66% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.24M |
| Shares Change (YoY) | -2.66% |
| Shares Change (QoQ) | -14.06% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | n/a |
| Float | 8.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | 111.91 |
| P/OCF Ratio | 83.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.90, with an EV/FCF ratio of 111.17.
| EV / Earnings | -23.32 |
| EV / Sales | 1.18 |
| EV / EBITDA | 26.90 |
| EV / EBIT | n/a |
| EV / FCF | 111.17 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.67 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 4.50 |
| Debt / FCF | 21.09 |
| Interest Coverage | -2.30 |
Financial Efficiency
Return on equity (ROE) is -14.76% and return on invested capital (ROIC) is -3.50%.
| Return on Equity (ROE) | -14.76% |
| Return on Assets (ROA) | -2.68% |
| Return on Invested Capital (ROIC) | -3.50% |
| Return on Capital Employed (ROCE) | -6.58% |
| Weighted Average Cost of Capital (WACC) | 3.59% |
| Revenue Per Employee | 696.37M |
| Profits Per Employee | -35.09M |
| Employee Count | 85 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 8.00 |
Taxes
In the past 12 months, Psomagen has paid 7.58 million in taxes.
| Income Tax | 7.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.14% in the last 52 weeks. The beta is -0.20, so Psomagen's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | +4.14% |
| 50-Day Moving Average | 3,568.30 |
| 200-Day Moving Average | 3,706.08 |
| Relative Strength Index (RSI) | 51.24 |
| Average Volume (20 Days) | 169,477 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Psomagen had revenue of KRW 59.19 billion and -2.98 billion in losses. Loss per share was -156.00.
| Revenue | 59.19B |
| Gross Profit | 14.49B |
| Operating Income | -2.25B |
| Pretax Income | -4.13B |
| Net Income | -2.98B |
| EBITDA | 2.93B |
| EBIT | -2.25B |
| Loss Per Share | -156.00 |
Balance Sheet
The company has 12.08 billion in cash and 13.20 billion in debt, with a net cash position of -1.12 billion or -57.99 per share.
| Cash & Cash Equivalents | 12.08B |
| Total Debt | 13.20B |
| Net Cash | -1.12B |
| Net Cash Per Share | -57.99 |
| Equity (Book Value) | 25.71B |
| Book Value Per Share | 1,451.25 |
| Working Capital | 10.41B |
Cash Flow
In the last 12 months, operating cash flow was 834.43 million and capital expenditures -208.75 million, giving a free cash flow of 625.67 million.
| Operating Cash Flow | 834.43M |
| Capital Expenditures | -208.75M |
| Depreciation & Amortization | 5.19B |
| Net Borrowing | 448.59M |
| Free Cash Flow | 625.67M |
| FCF Per Share | 32.53 |
Margins
Gross margin is 24.48%, with operating and profit margins of -3.81% and -5.04%.
| Gross Margin | 24.48% |
| Operating Margin | -3.81% |
| Pretax Margin | -6.97% |
| Profit Margin | -5.04% |
| EBITDA Margin | 4.95% |
| EBIT Margin | -3.81% |
| FCF Margin | 1.06% |
Dividends & Yields
Psomagen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.66% |
| Shareholder Yield | 2.66% |
| Earnings Yield | -4.26% |
| FCF Yield | 0.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Psomagen has an Altman Z-Score of 0.59 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.59 |
| Piotroski F-Score | 5 |